Management ChangeJul 15, 2026, 04:06 PM
Mobia Medical Appoints Reza Zadno to Board of Directors
AI Summary
Mobia Medical, Inc. announced the appointment of Reza Zadno, Ph.D., as an independent director to its Board of Directors, effective July 14, 2026. Dr. Zadno will also join the Compensation Committee. He brings over 35 years of medical technology experience, including leading companies like PROCEPT BioRobotics and Avedro through significant growth and IPOs, which is expected to be a complementary addition to Mobia Medical's Board.
Key Highlights
- Mobia Medical appointed Reza Zadno, Ph.D., as an independent director to its Board, effective July 14, 2026.
- Dr. Zadno will also serve as a member of the Compensation Committee.
- He brings over 35 years of medical technology experience, including leading companies through IPOs.
- Dr. Zadno previously served as President and CEO of PROCEPT BioRobotics (Nasdaq: PRCT) from 2020 to 2025.
- He also led Avedro as President and CEO from 2016 to 2020 before its acquisition.
- Dr. Zadno served on the boards of Invuity, Inc. and Carbylan Therapeutics.
Price Impact
More from MOBI